Viridian Therapeutics, Inc.\DE (VRDN) Preferred Shares (2021 - 2026)

Viridian Therapeutics, Inc.\DE's Preferred Shares history runs 7 years deep, the most recent figure standing at $61.2 million for Q1 2026.

• In Q1 2026, Preferred Shares fell 52.08% year-over-year to $61.2 million; the TTM figure through Mar 2026 stood at $61.2 million (down 52.08% YoY), while the FY2025 annual figure was $70.9 million, up 15.82% from the prior year.
• Preferred Shares for Q1 2026 stood at $61.2 million, down from $70.9 million in the prior quarter.
• The five-year high for Preferred Shares was $128.3 million in Q4 2023, with the low at $15.7 million in Q2 2022.
• The 5-year median for Preferred Shares is $78.2 million (2023), against an average of $84.1 million.
• The sharpest annual moves came in 2023 and 2024: Preferred Shares soared 399.3% in 2023, then slumped 52.3% in 2024.
• Viridian Therapeutics, Inc.\DE's Preferred Shares stood at $85.5 million in 2022, then jumped by 50.09% to $128.3 million in 2023, then plunged by 52.3% to $61.2 million in 2024, then gained by 15.82% to $70.9 million in 2025, then slipped by 13.66% to $61.2 million in 2026.
• Business Quant data shows VRDN's Preferred Shares at $61.2 million in Q1 2026, $70.9 million in Q4 2025, and $61.2 million in Q3 2025.